BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38310787)

  • 1. Concurrent rectal perforation and obstruction following neoadjuvant chemoradiation for locally advanced rectal cancer: A case report.
    Tahouri T; Hedayati Omami S; Hosseini M; Rahimi-Movaghar E
    Int J Surg Case Rep; 2024 Mar; 116():109337. PubMed ID: 38310787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic relevance of programmed cell death-ligand 1 expression and CD8+ TILs in rectal cancer patients before and after neoadjuvant chemoradiotherapy.
    Chen TW; Huang KC; Chiang SF; Chen WT; Ke TW; Chao KSC
    J Cancer Res Clin Oncol; 2019 Apr; 145(4):1043-1053. PubMed ID: 30874889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of life in a randomized trial comparing two neoadjuvant regimens for locally advanced rectal cancer-INCAGI004.
    Araujo RO; Vieira FM; Victorino AP; Torres C; Martins I; Guaraldi S; Valadão M; Linhares E; Ferreira CG; Thuler LC
    Support Care Cancer; 2022 Aug; 30(8):6557-6572. PubMed ID: 35486228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Machine Learning-Based Prediction of Responsiveness to Neoadjuvant Chemoradiotheapy in Locally Advanced Rectal Cancer Patients from Endomicroscopy.
    Sabino AU; Safatle-Ribeiro AV; Lima SS; Marques CFS; Maluf-Filho F; Ramos AF
    Crit Rev Oncog; 2024; 29(2):53-63. PubMed ID: 38505881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computertomography-Based Prediction of Complete Response Following Neoadjuvant Chemoradiotherapy of Locally Advanced Rectal Cancer.
    Maslova M; Herden H; Schork K; Turewicz M; Eisenacher M; Schroers R; Baraniskin A; Mika T
    Front Oncol; 2021; 11():623144. PubMed ID: 34136378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Programmed death-ligand 1 and mammalian target of rapamycin signaling pathway in locally advanced rectal cancer.
    Feng Y; Luo J; Liu P; Zhu Y; Cheng G; Zheng L; Liu L
    Discov Oncol; 2022 Feb; 13(1):10. PubMed ID: 35201501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ypTNM category combined with AJCC tumor regression grade for screening patients with the worst prognosis after neoadjuvant chemoradiation therapy for locally advanced rectal cancer.
    Wei J; Huang R; Guo S; Zhang X; Xi S; Wang Q; Chang H; Wang X; Xiao W; Zeng Z; Gao Y
    Cancer Manag Res; 2018; 10():5219-5225. PubMed ID: 30464619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoadjuvant PET and MRI-based intensity modulated radiotherapy leads to less toxicity and improved pathologic response rates in locally advanced rectal cancer.
    David JM; Gresham G; Jabbour SK; Deek M; Thomassian S; Robertson JM; Newman NB; Herman JM; Osipov A; Kabolizadeh P; Tuli R
    J Gastrointest Oncol; 2018 Aug; 9(4):641-649. PubMed ID: 30151260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rectal perforation following paclitaxel and carboplatin chemotherapy for advanced ovarian cancer: a case report and review of the literature.
    Jayakody S; Wright DB; Chiong C; Liu M; Bouffler C; El-Khoury T
    J Med Case Rep; 2018 Aug; 12(1):221. PubMed ID: 30111379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can an IL13 -1112 C/T (rs1800925) polymorphism predict responsiveness to neoadjuvant chemoradiotherapy and survival of Chinese Han patients with locally advanced rectal cancer?
    Xiao L; Yu X; Zhang R; Chang H; Xi S; Xiao W; Zeng Z; Zhang H; Xu R; Gao Y
    Oncotarget; 2016 Jun; 7(23):34149-57. PubMed ID: 27167201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of Dose-Escalated Chemoradiation on Complete Tumor Response in Patients with Locally Advanced Rectal Cancer (RECTAL-BOOST): A Phase 2 Randomized Controlled Trial.
    Couwenberg AM; Burbach JPM; Berbee M; Lacle MM; Arensman R; Raicu MG; Wessels FJ; Verdult J; Roodhart J; Reerink O; Hoendervangers S; Buijsen J; Grabsch HI; Pronk A; Consten ECJ; Smits AB; Heikens JT; Appelt AL; van Grevenstein WMU; Verkooijen HM; Intven MPW
    Int J Radiat Oncol Biol Phys; 2020 Nov; 108(4):1008-1018. PubMed ID: 32565319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of pathological complete response rates after neoadjuvant short-course radiotherapy or chemoradiation followed by delayed surgery in locally advanced rectal cancer.
    Hoendervangers S; Couwenberg AM; Intven MPW; van Grevenstein WMU; Verkooijen HM
    Eur J Surg Oncol; 2018 Jul; 44(7):1013-1017. PubMed ID: 29650419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Organ Preservation in Rectal Adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and total mesorectal excision or nonoperative management.
    Smith JJ; Chow OS; Gollub MJ; Nash GM; Temple LK; Weiser MR; Guillem JG; Paty PB; Avila K; Garcia-Aguilar J;
    BMC Cancer; 2015 Oct; 15():767. PubMed ID: 26497495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors].
    Ouyang GL; Meng WJ; Shu P; Deng XB; Wu B; Jiang D; Zhuang H; Shen YL; Zhou ZG; Wang ZQ; Wang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):349-356. PubMed ID: 31054549
    [No Abstract]   [Full Text] [Related]  

  • 15. [Chronic radiation-induced rectal injury after adjuvant radiotherapy for pelvic malignant tumors: report based on a phase 3 randomized clinical trial].
    Zhou Y; Huang H; Wan T; Feng YL; Liu JH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Nov; 24(11):962-968. PubMed ID: 34823296
    [No Abstract]   [Full Text] [Related]  

  • 16. Neutrophil-to-Lymphocyte Ratio (NLR) as a Poor Predictive Biomarker for Pathological Response to Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer: A Prospective Study.
    Novin K; Fadavi P; Mortazavi N; Sanei M; Khoshbakht Ahmadi H; Barahman M; Noori R; Hoveidamanesh S; Shahin M; Taghizadeh-Hesary F
    Asian Pac J Cancer Prev; 2023 Jan; 24(1):61-67. PubMed ID: 36708552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Syphilitic proctitis presenting as locally advanced rectal cancer: A case report.
    Peine B; Ved KJ; Fleming T; Sun Y; Honaker MD
    Int J Surg Case Rep; 2023 Jun; 107():108358. PubMed ID: 37267792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Rare Presentation of Small Bowel Perforation Secondary to Microscopic Metastasis of Non-small Cell Lung Cancer (NSCLC): A Case Report.
    Alhusari L; Abdallah M; Al-Madani A; Nwanwene K; Lawrence LM; Pacioles T
    Cureus; 2023 Dec; 15(12):e50383. PubMed ID: 38213343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe myositis of the hip flexors after pre-operative chemoradiation therapy for locally advanced rectal cancer: case report.
    Florczynski MM; Sanatani MS; Mai L; Fisher B; Moulin DE; Cao J; Louie AV; Pope JE; Leung E
    BMC Cancer; 2016 Mar; 16():243. PubMed ID: 27000107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.